Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.
Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial,
Introducing Oncotarget.
As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.
Publication Alerts
Subscribe to receive alerts once a paper has been published by Oncotarget.
Michele Ammendola, Cosmo Damiano Gadaleta, Adam Enver Frampton, Tullio Piardi, Riccardo Memeo, Valeria ZuccalÃ, Maria Luposella, Rosa Patruno, Nicola Zizzo, Pietro Gadaleta, Patrick Pessaux, Rosario Sacco, Giuseppe Sammarco, Girolamo Ranieri
Published Jul 31, 2017 · Vol. 8, No. 41 · pp. 70463-70471
Jia-Min B. Pang, Ramyar Molania, Ashwini Chand, Kevin Knower, Elena A. Takano, David J. Byrne, Thomas Mikeska, Ewan K.A. Millar, Cheok Soon Lee, Sandra A. O’Toole, Colin Clyne, Kylie L. Gorringe, Alexander Dobrovic, Stephen B. Fox
Published Jul 28, 2017 · Vol. 8, No. 48 · pp. 83626-83636